Medicare Enrolled
Dr. Andrew Kramer, M.D.
Urology Physician · Hyannis, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kramer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kramer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kramer
Dr. Andrew Kramer is an urology physician in Hyannis, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kramer performed 4,156 Medicare services across 1,342 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kramer received a total of $138,816 from 51 pharmaceutical and/or device companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kramer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 26% volume in MA
$138,816 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,156
Medicare services
Top 26% in MA for urology physician
1,342
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~208 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
2,303 | $34 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
724 | $95 | $426 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
179 | $34 | $100 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
179 | $34 | $100 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
179 | $34 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $110 | $550 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
80 | $192 | $650 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
61 | $61 | $225 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
51 | $40 | $150 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
51 | $88 | $596 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
31 | $8 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $139 | $600 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
27 | $4 | $15 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
22 | $23 | $300 |
| Surgery to correct abnormal penis angle A surgical procedure performed to straighten the penis by correcting an abnormal curvature or angle. |
21 | $291 | $1,685 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
20 | $30 | $184 |
| Insertion of multicomponent inflatable penile implant | 18 | $636 | $2,000 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $64 | $175 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
15 | $20 | $150 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
12 | $158 | $550 |
| Endoscopic removal of urethral or bladder foreign body A procedure to remove a stone, stent, or other object from the urethra or bladder using an endoscope. The endoscope allows the provider to visualize and extract the item through the urinary tract. |
11 | $387 | $1,200 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
11 | $305 | $1,582 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
3.3% medium
95.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$138,816
Total received (2018-2024)
Avg $19,831/year across 7 years
Top 3% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
266
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$104,528 (75.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,175 (15.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,113 (9.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,597
2023
$22,041
2022
$493
2021
$2,835
2020
$36,062
2019
$31,846
2018
$42,942
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,568
Teleflex LLC
$361
Olympus America Inc.
$112
ABBVIE INC.
$79
Tolmar, Inc.
$78
ACCORD HEALTHCARE, INC.
$76
Becton, Dickinson and Company
$57
180 Medical, Inc.
$57
Sumitomo Pharma America, Inc.
$42
Dendreon Pharmaceuticals LLC
$34
Antares Pharma, Inc.
$27
Endo USA, Inc.
$25
Ferring Pharmaceuticals Inc.
$23
IMMUNITYBIO, INC.
$22
Myriad Genetic Laboratories, Inc.
$18
C. R. Bard, Inc. & Subsidiaries
$17
Top 3 companies account for 78.6% of 2024 payments
All-time payments by company (2018-2024) ›
Rigicon,Inc.
$43,081
Boston Scientific Corporation
$42,610
BOSTON SCIENTIFIC CORPORATION
$35,915
Coloplast Corp
$12,339
BAXTER HEALTHCARE
$880
Teleflex LLC
$762
PROCEPT BioRobotics Corporation
$416
Baxter Healthcare
$383
Janssen Biotech, Inc.
$253
ABBVIE INC.
$176
180 Medical, Inc.
$150
Tolmar, Inc.
$150
UROGEN PHARMA, INC.
$144
Olympus America Inc.
$129
Progenics Pharmaceuticals, Inc.
$122
Antares Pharma, Inc.
$118
Ferring Pharmaceuticals Inc.
$118
Sumitomo Pharma America, Inc.
$96
ACCORD HEALTHCARE, INC.
$76
Becton, Dickinson and Company
$57
AbbVie Inc.
$51
Astellas Pharma US Inc
$48
Axonics, Inc.
$46
Myriad Genetic Laboratories, Inc.
$45
C. R. Bard, Inc. & Subsidiaries
$42
Allergan Inc.
$40
Bayer Healthcare Pharmaceuticals Inc.
$35
Innovation Technologies Inc
$35
Dendreon Pharmaceuticals LLC
$34
UROVANT SCIENCES INC
$31
Supernus Pharmaceuticals, Inc.
$29
Blue Earth Diagnostics Limited
$29
Endo Pharmaceuticals Inc.
$28
HealthTronics Mobile Solutions, LLC
$27
Endo USA, Inc.
$25
Allergan, Inc.
$23
IMMUNITYBIO, INC.
$22
Acerus Pharmaceuticals Corporation
$22
KARL STORZ Endoscopy-America
$21
Alnylam Pharmaceuticals Inc.
$21
Osiris Therapeutics Inc.
$21
Foundation Medicine, Inc.
$20
Merck Sharp & Dohme Corporation
$19
Telix Pharmaceuticals
$18
Retrophin, Inc.
$18
Myovant Sciences Inc.
$18
Medtronic, Inc.
$16
Axonics Modulation Technologies, Inc.
$15
TOLMAR Pharmaceuticals, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
PFIZER INC.
$13
Top 3 companies account for 87.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 8.5 FR. X 675MM · ADSTILADRIN · AMS · AMS 700 · AMS 700 CXR RTE Kit · ANKTIVA · AVEED · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CMOS VIDEO URETEROSCOPE · CONTINENCE CARE · CURE CATHETER · ELIGARD · ERLEADA · Endocare Cryocare System · Erleada · FIRMAGON · FLOSEAL · FOUNDATIONONE · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL MALE SUI · GENERAL THERAPIES · GENERAL - ERECTILE DYSFUNCTION · GENERAL - THERAPIES · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL THERAPIES · GENTLECATH · GENTLECATH GLIDE · GRAFIX/GRAFIXPL/STRAVIX · GREENLIGHT · ILLUCCIX · INTERSTIM · IRRISEPT · JELMYTO · LUPRON DEPOT · LYNPARZA · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · No Related Product · Nubeqa · ONPATTRO · OPDIVO · ORGOVYX · OTREXUP · Olympus Cysto-Resection · Otrexup · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · RIGI10 MALLEABLE PENILE PROSTHESIS · RIGI10 MALLEABLE PENILE PROSTHESOS · Rigi10 Malleable Penile Prosthesis · SpeediCath · TACHOSIL · THERAPIES · TISSEEL · TITAN · TLANDO · Titan · UROLIFT · UroLift System · XIAFLEX · XYOSTED · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for urology physician in MA.
Geographic Context
Urology physicians within 10 mi
13
Per 100K population
5.7
County median income
$94,452
Nearest hospital
CAPE COD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kramer is a clinical cardiology specialist, with above-average Medicare volume (top 26% in MA), with speaking/promotional industry engagement in the top 3% of MA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kramer experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Kramer performed 2,303 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kramer receive payments from pharmaceutical companies?
Yes. Dr. Kramer received a total of $138,816 from 51 companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kramer's costs compare to other urology physicians in Hyannis?
Dr. Kramer's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kramer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Hyannis
Browse urology physicians in Hyannis ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Rigicon,Inc. Payments to Doctors
See all physicians who received payments from Rigicon,Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology